NCT00699231View on ClinicalTrials.gov

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 29, 1992

Primary Completion Date

December 31, 1992

Study Completion Date

December 31, 1992

Conditions

Hepatitis B

Interventions

BIOLOGICAL

HBV-MPL vaccine 208129

IM injection

BIOLOGICAL

Engerix™-B

IM injection

Trial Locations (1)

Unknown

GSK Clinical Trials Call Center, Brussels

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY